ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1444

Differential Expression of Wnt Inhibitors before and after Joint Inflammation Onset in Rat Arthritis Could Partly Explain Paradoxical Effect of Sclerostin Inhibition

Guillaume Courbon1, Raphaelle Lamarque2, Marie-Thérèse Linossier2, Norbert Laroche2, Thierry Thomas3, Laurence Vico2 and Hubert Marotte3, 1SAINBIOSE INSERM U1059, University of Lyon, Saint-Etienne, France, 2SAINBIOSE INSERM U1059, University of Lyon, Saint Etienne, France, 3SAINBIOSE INSERM U1059 and Rheumatology department, University of Lyon and University Hospital of Saint Etienne, Saint Etienne, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Animal models, arthritis and bone remodeling, Imaging, WNT Signaling

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Periarticular bone loss in rheumatoid arthritis is considered to be mainly related to synovial inflammation, leading to uncoupling between decreased bone formation and increased bone resorption. However, it has been recently demonstrated a paradoxical exacerbation of joint damage when blocking sclerostin in various arthritis models. Phase specific changes in Wnt pathway activity over the course of the disease could participate in the underlying mechanisms of these results. Thus, we proposed to determine kinetic expressions of Wnt inhibitors in a classic rodent model of arthritis, the rat adjuvant induced arthritis (AIA).

Methods:  Arthritis was induced (AIA, n=35) or not (CTRL, n=35) at baseline. Inflammation and loss of articular function were monitored. Periarticular bone loss and joint damage were evaluated before, during and after arthritis onset in a 7 time-point follow-up, using micro-computed tomography (µ-CT) and histomorphometry. Gene expressions were assessed by quantitative RT-PCRs at each time point.

Results:  AIA onset occurred at day 12 post-induction (p<0.001). Surprisingly, histomorphometry and µ-CT showed bone alterations as early as day 8. Indeed, cortical porosity increased and trabecular network was significantly impaired (p<0.01). Moreover, these early bone alterations before arthritis onset predicted arthritis severity outcome. As expected, gene expression confirmed an early upregulation of bone resorption markers like RANKL from day 8 to day 24 (p<0.01). More interestingly, expression of bone formation inhibitors followed a specific pattern with SOST upregulation only before arthritis onset (p<0.01) and return to normal expression afterwards. However, frizzled related protein 1 (SFRP1) expression only increased after arthritis onset (p<0.01). Furthermore, dickkopf related protein 1 (DKK1) expression increased before and after arthritis onset with a low expression during arthritis onset. Figure: gene expression pattern of SOST, DKK1, and SFRP1.

Conclusion:  Bone alterations before arthritis onset supports the hypothesis of an early involvement of bone compartment in arthritis. The specific pattern of sclerostin expression suggested that sclerostin might play dual effects depending on arthritis phases. In addition, SFRP1 later increased expression could play a strong role in bone formation alteration related to arthritis. Since DKK-1 was highly expressed before and after arthritis onset, its blockade was already described to be efficient in mice arthritic model. We infer from our results that better deciphering Wnt pathway changes during arthritis is required before using biologics targeting this pathway for preventing periarticular bone loss.


Disclosure: G. Courbon, None; R. Lamarque, None; M. T. Linossier, None; N. Laroche, None; T. Thomas, None; L. Vico, None; H. Marotte, None.

To cite this abstract in AMA style:

Courbon G, Lamarque R, Linossier MT, Laroche N, Thomas T, Vico L, Marotte H. Differential Expression of Wnt Inhibitors before and after Joint Inflammation Onset in Rat Arthritis Could Partly Explain Paradoxical Effect of Sclerostin Inhibition [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/differential-expression-of-wnt-inhibitors-before-and-after-joint-inflammation-onset-in-rat-arthritis-could-partly-explain-paradoxical-effect-of-sclerostin-inhibition/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-expression-of-wnt-inhibitors-before-and-after-joint-inflammation-onset-in-rat-arthritis-could-partly-explain-paradoxical-effect-of-sclerostin-inhibition/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology